NM_017763.6:c.350G>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017763.6(RNF43):​c.350G>A​(p.Arg117His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 1,605,284 control chromosomes in the GnomAD database, including 16,938 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.

Frequency

Genomes: 𝑓 0.15 ( 1963 hom., cov: 32)
Exomes 𝑓: 0.13 ( 14975 hom. )

Consequence

RNF43
NM_017763.6 missense

Scores

1
7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.00
Variant links:
Genes affected
RNF43 (HGNC:18505): (ring finger protein 43) The protein encoded by this gene is a RING-type E3 ubiquitin ligase and is predicted to contain a transmembrane domain, a protease-associated domain, an ectodomain, and a cytoplasmic RING domain. This protein is thought to negatively regulate Wnt signaling, and expression of this gene results in an increase in ubiquitination of frizzled receptors, an alteration in their subcellular distribution, resulting in reduced surface levels of these receptors. Mutations in this gene have been reported in multiple tumor cells, including colorectal and endometrial cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
TSPOAP1-AS1 (HGNC:44148): (TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032409728).
BP6
Variant 17-58370936-C-T is Benign according to our data. Variant chr17-58370936-C-T is described in ClinVar as [Benign]. Clinvar id is 1165517.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-58370936-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNF43NM_017763.6 linkc.350G>A p.Arg117His missense_variant Exon 3 of 10 ENST00000407977.7 NP_060233.3 Q68DV7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNF43ENST00000407977.7 linkc.350G>A p.Arg117His missense_variant Exon 3 of 10 2 NM_017763.6 ENSP00000385328.2 Q68DV7-1
ENSG00000285897ENST00000648873.1 linkn.350G>A non_coding_transcript_exon_variant Exon 2 of 13 ENSP00000497686.1 A0A3B3ITA1

Frequencies

GnomAD3 genomes
AF:
0.148
AC:
22491
AN:
151854
Hom.:
1958
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.0981
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.375
Gnomad SAS
AF:
0.313
Gnomad FIN
AF:
0.148
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.108
Gnomad OTH
AF:
0.128
GnomAD3 exomes
AF:
0.158
AC:
38482
AN:
243942
Hom.:
4107
AF XY:
0.164
AC XY:
21617
AN XY:
131756
show subpopulations
Gnomad AFR exome
AF:
0.189
Gnomad AMR exome
AF:
0.0710
Gnomad ASJ exome
AF:
0.165
Gnomad EAS exome
AF:
0.386
Gnomad SAS exome
AF:
0.291
Gnomad FIN exome
AF:
0.151
Gnomad NFE exome
AF:
0.109
Gnomad OTH exome
AF:
0.133
GnomAD4 exome
AF:
0.128
AC:
185550
AN:
1453312
Hom.:
14975
Cov.:
31
AF XY:
0.132
AC XY:
95544
AN XY:
722512
show subpopulations
Gnomad4 AFR exome
AF:
0.187
Gnomad4 AMR exome
AF:
0.0743
Gnomad4 ASJ exome
AF:
0.166
Gnomad4 EAS exome
AF:
0.354
Gnomad4 SAS exome
AF:
0.290
Gnomad4 FIN exome
AF:
0.146
Gnomad4 NFE exome
AF:
0.105
Gnomad4 OTH exome
AF:
0.143
GnomAD4 genome
AF:
0.148
AC:
22517
AN:
151972
Hom.:
1963
Cov.:
32
AF XY:
0.154
AC XY:
11419
AN XY:
74256
show subpopulations
Gnomad4 AFR
AF:
0.186
Gnomad4 AMR
AF:
0.0982
Gnomad4 ASJ
AF:
0.156
Gnomad4 EAS
AF:
0.374
Gnomad4 SAS
AF:
0.312
Gnomad4 FIN
AF:
0.148
Gnomad4 NFE
AF:
0.108
Gnomad4 OTH
AF:
0.132
Alfa
AF:
0.118
Hom.:
3334
Bravo
AF:
0.143
TwinsUK
AF:
0.110
AC:
408
ALSPAC
AF:
0.107
AC:
414
ESP6500AA
AF:
0.185
AC:
816
ESP6500EA
AF:
0.109
AC:
936
ExAC
AF:
0.160
AC:
19385
Asia WGS
AF:
0.341
AC:
1186
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 18, 2024
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jun 15, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

RNF43-related disorder Benign:1
Nov 04, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
23
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.23
T;T;T
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Benign
0.73
D
LIST_S2
Uncertain
0.86
.;.;D
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.55
N;N;N
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-2.4
N;.;.
REVEL
Benign
0.14
Sift
Uncertain
0.0010
D;.;.
Sift4G
Uncertain
0.016
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.14
MPC
0.53
ClinPred
0.019
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.54
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2257205; hg19: chr17-56448297; COSMIC: COSV68457011; API